分析选择性COX-2抑制剂治疗腰椎间盘突出症的疗效  

作　　者：张星晨[1] 

机构地区：[1]徐州医学院,江苏徐州221000

出　　处：《临床医药文献电子杂志》2015年第3期505-505,共1页Electronic Journal of Clinical Medical Literature

摘　　要：目的：分析探讨选择性COX-2抑制剂在腰椎间盘突出症保守治疗患者中的疗效。方法将笔者实习科室2014年3月～2014年7月间收治40例腰椎间盘突出症患者，男16例，女24例，年龄46～73岁，平均年龄58.2岁，随机分为塞来昔布组和安慰剂组各20例，比较两组患者间疗效的差异。结果塞来昔布组与安慰剂组的总有效率比较差异有统计学意义。结论 COX-2抑制剂治疗早起腰椎间盘突出症有效、安全，值得推广。Objective Analysis to study the selective cox-2 inhibitors in conservative treatment efficacy in patients with lumbar disc prolapse.Methods The author practice department in March 2014 to July 2014 were 40 cases of patients with lumbar disc prolapse, including 16 cases of male, female 24 age 46-73, the average age of 58.2 years, were randomly divided into celecoxib group and placebo group 20 cases, comparing the difference between the curative effect between the two groups of patients.Results Celecoxib group compared with the placebo group total effective rate difference was statistically significant.Conclusion Cox-2 inhibitors treatment is effective, safe, and the early lumbar intervertebral disc protrusion is worth promoting.

关 键 词：OX-2抑制剂 腰椎间盘突出症 保守治疗 

分 类 号：R944[医药卫生—药剂学]